Pictet Asset Management Holding SA »

Y Mabs Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.0M 688k 13.15
2024-03-31 $12M 746k 16.26

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Y Mabs Therapeutics

Paradigm Biocapital Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Cormorant Asset Management
Caligan Partners
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Pictet Asset Management Holding SA
Soleus Capital Management
Dimensional Fund Advisors
Northern Trust
Citadel Advisors

View all funds holding Y Mabs Therapeutics